Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.

@article{Davis2016DiseaseRR,
  title={Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.},
  author={John W Davis and John F. Ward and Curtis A. Pettaway and Xuemei Wang and Deborah Ann Kuban and Steven J Frank and Andrew K. Lee and Louis Pisters and Surena F Matin and Jay Bakul Shah and Jose A Karam and Brian Francis Chapin and John N. Papadopoulos and Mary F. Achim and Karen Elizabeth Hoffman and Thomas J. Pugh and Seungtaek Choi and P. Brunny Troncoso and Christopher J. Logothetis and Jeri Kim},
  journal={BJU international},
  year={2016},
  volume={118 1},
  pages={68-76}
}
OBJECTIVES To determine the frequency of disease reclassification and to identify clinicopathological variables associated with it in patients with favourable-risk prostate cancer undergoing active surveillance (AS). PATIENTS AND METHODS We assessed 191 men, selected by what may be the most stringent criteria used in AS studies yet conducted, who were enrolled in a prospective cohort AS trial. Clinicopathological characteristics were analysed in a multivariate Cox proportional hazards… CONTINUE READING